Ensure Long-Acting Beta-Agonists Aren't Used Alone for Asthma

New evidence will bring up questions about the role of long-acting beta-agonists (LABAs) for asthma.

We've heard about early studies that suggest using a LABA withOUT an inhaled corticosteroid (ICS) increases the risk of asthma death.

This led to Health Canada's warnings in 2005 to stop LABAs once asthma is controlled.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote